Ascentage Pharma Group International (AAPG) Non-Current Assets (2023 - 2024)
Ascentage Pharma Group International (AAPG) has 2 years of Non-Current Assets data on record, last reported at $159.2 million in Q4 2024.
- For Q4 2024, Non-Current Assets rose 185.28% year-over-year to $159.2 million; the TTM value through Dec 2024 reached $159.2 million, changed N/A, while the annual FY2024 figure was $159.2 million, 183.68% up from the prior year.
- Non-Current Assets reached $159.2 million in Q4 2024 per AAPG's latest filing, up from -$186.7 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $159.2 million in Q4 2024 and bottomed at -$186.7 million in Q4 2023.